Medical/Pharmaceuticals

Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing

SHANGHAI, March 3, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly$100 million Series C financing. This round was co-led by Qiming Venture Partners and existing share...

2025-03-03 08:00 4859

Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

SAN FRANCISCO and SUZHOU, China, March 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli...

2025-03-03 08:00 5680

Hospital Kuala Lumpur & Rare Disease Patient Organizations Nationwide Celebrate Rare Disease Day 2025

KUALA LUMPUR, Malaysia, March 1, 2025 /PRNewswire/ -- For the first time, Hospital Kuala Lumpur (HKL) is proudly hosting the annual Rare Disease Day 2025 celebration to raise awareness and advocate for individuals affected by rare diseases inMalaysia. This milestone event is organized by the Depa...

2025-03-01 22:30 5271

Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs

SHANGHAI, Feb. 28, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines, today announced that it will hold investor...

2025-02-28 14:28 5435

EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements

PROVIDENCE, R.I., Feb. 27, 2025 /PRNewswire/ -- EpiVax, Inc. proudly announces the appointment ofGuilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax's immunoinformatics team in 2014 and spearheaded the development of a new computational platform for developing personalized, neo...

2025-02-27 22:05 3562

Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its Industry-leading Integrated Bioinformatics Platform

Metabolon's expertise extends beyond metabolomics to include data insights and software solutions for multiomics research MORRISVILLE, N.C., Feb. 27, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, dia...

2025-02-27 22:00 2694

Nezha Craze Sweeps the City Wai Yuen Tong Proudly Sponsors Broadcast of "Nezha: The Demon Child Comes into the World" on Jade Channel

HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Hong Kong's traditional Chinese medicine pioneer Wai Yuen Tong (0897.HK) announced its proud sponsorship of the TVB Jade Channel's broadcast of the film " Nezha:  The Demon Child Comes into the World " (Nezha 1) onFebruary 28 at 8 PM. This film will provid...

2025-02-27 20:09 4485

WuXi Biologics Again Passed GMP Inspection by Japan PMDA

WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection byJapan's Pharmaceuticals and Medical Devices Agency (PMDA) for it...

2025-02-27 16:30 3930

Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America

New insights from Clarivate examine strategic partnerships, API production, and innovation in the region LONDON, Feb. 27, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, has released a new white paper, How is Latin America Growing?, sheddi...

2025-02-27 16:00 2416

Alpro Foundation & Universiti Teknologi MARA: Addressing Malaysia's Pharmaceutical Waste

KUALA LUMPUR, Malaysia, Feb. 27, 2025 /PRNewswire/ -- Malaysia is facing a growing environmental and public health threat due to improper disposal of pharmaceutical waste. Research indicates that 67% of Malaysians discard expired medications incorrectly—either by flushing them down the toilet or ...

2025-02-27 15:19 3214

Revolutionizing All-on-X: Medit's Game-Changing Workflow Will Launch Soon

SEOUL, South Korea and NEWPORT BEACH, Calif., Feb. 27, 2025 /PRNewswire/ -- Medit (www.medit.com ), a global leader in digital dentistry, is set to revolutionize the digital All-on-X workflow, making it more accessible, efficient, and intuitive for Medit scanner users. <...

2025-02-27 15:00 7104

First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer

SUZHOU, China, Feb. 27, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-301) of anti-HER2 bip...

2025-02-27 14:06 4805

The debate on MSCs is over; it's time to promote MSC therapy in practice

TIANJIN, China, Feb. 27, 2025 /PRNewswire/ -- The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for more than two decades (since 2006), being the major obstacle for MSCs study and clinical application. The major issue focuses on mesenchymal stem cells could no...

2025-02-27 12:57 4617

Neopharma Technologies Announces Strategic Partnership with AusChain to Assist with the Scaling and Global Rollout of NEOVAULT®

PERTH, Australia, Feb. 27, 2025 /PRNewswire/ -- Neopharma Technologies Ltd (Neopharma) is pleased to announce a strategic partnership with AusChain Pty Ltd, a global leader in scalable blockchain solutions specializing in product traceability through QR codes. AusChain has successfully implemente...

2025-02-27 12:01 3804

AIM Vaccine's mRNA RSV Vaccine Approved for U.S. Clinical Trials

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) HONG KONG, Feb. 27, 2025 /PRNewswire/ -- The stocks in the Hong Kong pharmaceutical sector have ...

2025-02-27 08:00 4722

ZEISS VISUMAX 800 with SMILE pro software receives approval in China

Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow  JENA, Germany and SHANGHAI, Feb. 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) ...

2025-02-27 07:00 3854

McCrae Hospitals and Orion Health expand Viet Nam footprint through key partnerships

AUCKLAND, New Zealand, Feb. 27, 2025 /PRNewswire/ -- A signing ceremony with New Zealand Prime Minister Christopher Luxon and Franco-Vietnamese (FV) Hospital Group inHo Chi Minh City, Viet Nam yesterday marked the first milestone in preparation for the launch of ambitious Kiwi health tech innova...

2025-02-27 06:00 3443

Perennial Tianjin Medical Cluster, Including China's First Wholly Foreign-Owned Private Tertiary General Hospital, Officially Opened

Separate MOUs signed with SingHealth for bilateral cross-border knowledge exchange,  and with Tianjin Academy of TCM for expansion into Singapore SINGAPORE, Feb. 26, 2025 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") marked a major milestone today with the official ope...

2025-02-26 23:56 5950

ECR 2025: Esaote Group presents Integrated Medical Imaging Solutions and unveils innovations in Ultrasound Technology

Ebit showcases SUITESTENSA ZEfiRO: the new "cloud-native" PACS with diagnostic viewer VIENNA, Feb. 26, 2025 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging - ultrasound, dedicated magnetic resonance and medical IT -presents its new portfolio of imaging solutions at t...

2025-02-26 21:00 3669

RESPIREE SECURES SINGAPORE HSA CLEARANCE FOR PEDIATRIC EXPANSION OF CARDIO-RESPIRATORY WEARABLE AND FOR ITS NEW EHR STREAMLINED PLATFORM

SINGAPORE, Feb. 26, 2025 /PRNewswire/ -- AI/ML health tech startup Respiree has received clearance from the Health Sciences Authority (HSA) to extend its RS001 cardio-respiratory wearable to pediatric populations. This clearance also enables the extension of Respiree's...

2025-02-26 17:21 3403
1 ... 116117118119120121122 ... 381